TG Therapeutics (NASDAQ:TGTX) Price Target Raised to $72.00

Дата публикации: 10-08-2026 05:48:47

TG Therapeutics (NASDAQ:TGTX – Free Report) had its price objective hoisted by JPMorgan Chase & Co. from $65.00 to $72.00 in a research report sent to investors on Friday,Benzinga reports. The firm currently has an overweight rating on the biopharmaceutical company’s stock. A number of other equities analysts also recently weighed in on the stock. […]

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Odyssey Therapeutics (NASDAQ:ODTX) Price Target Raised to $29.00	0	14.24	10-08-2026
2	JFrog (NASDAQ:FROG) Price Target Raised to $115.00	0	14.6	10-08-2026
3	Qiagen (NYSE:QGEN) Price Target Raised to $50.00	0	14.26	10-08-2026
4	Genpact (NYSE:G) Price Target Raised to $45.00	0	14.26	10-08-2026
5	Natera (NASDAQ:NTRA) Price Target Raised to $360.00	0	14.27	10-08-2026
6	Rhythm Pharmaceuticals (NASDAQ:RYTM) Price Target Raised to $146.00	0	14.22	10-08-2026
7	Haemonetics (NYSE:HAE) Price Target Raised to $86.00	0	14.69	10-08-2026
8	Maplebear (NASDAQ:CART) Price Target Raised to $62.00	0	13.46	10-08-2026
9	Goodyear Tire & Rubber (NASDAQ:GT) Price Target Raised to $10.00	0	14.2	10-08-2026
10	JPMorgan Chase & Co. Cuts Zoetis (NYSE:ZTS) Price Target to $115.00	0	12.26	10-08-2026

Классификация: Экономика. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 13.04. Источник: www.americanbankingnews.com.